Trade Summary

Yesterday, Goodman Noah, serving as Chief Business Officer at Kymera Therapeutics, Inc. (KYMR), sold 2,500 shares at $99.00 per share, for a total transaction value of $247,500.00. Following this transaction, Goodman Noah now holds 50,195 shares of KYMR.

This sale represents a 4.74% decrease in Goodman Noah's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, June 22, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 22, 2026 at 5:47 PM ET, meaning the disclosure happened on the same day as the trade.

Kymera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.